Davey FR, Abraham Jr N, Brunetto VL, MacCallum JM, Nelson DA, Ball ED et al. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): A CALGB study. Am J Hematol 1995; 49: 29-38.
Kowal-Vem A, Mazzella FM, Cotelingam JD, Shrit MA, Rector JT, Schumacher HR. Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases. Am J Hematol 2000; 65: 5-13.
Kosmider O, Denis N, Lacout C, Vainchenker W, Dubreuil P, Moreau-Gachelin F. Kit-activating mutations cooperate with Spi-1/PU 1 overexpression to promote tumorigenic progression during erythroleukemia in mice. Cancer Cell 2005; 8: 467-478.
Ferreira R, Ohneda K, Yamamoto M, Philipsen S. GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol Cell Biol 2005;25:1215-1227.
James C, Ugo V, Le Couedic JP, Staerk J, Drelhommeau F, Lacout C et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144-1148.
Boissel N, Leroy H, Brethon B, Philippe N, de Botton S, Auvrignon A et al. Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML). Leukemia 2006; 20: 965-970.
